Annual Report of Drug and Poison Information in Iran From March 2012 to March 2013
Drug and Poison Information Centers (DPICs) have a critical role in the fulfillment of rational drug use programs and provide services to the scientific community with the aim of improving the health and safety of drug use. This was a retrospective study on recorded calls of DPICs in Iran from March 2012 to March 2013. Data consisted of general information; drug and poisoning information, medical history and also the distribution of a number of calls collected by DPICs in Iran. The centers received a total of 171769 calls. Most calls were made by the patients (56.1%) and then the patients’ relatives (38%). Also, 67% of the patients were determined as female. The calls mostly were focused on Adverse Drug Reactions (ADR) (15.3%), indications (14.0%) and drug evaluations (11.8%). Anti-infective agents, non-steroidal anti-inflammatory drugs (NSAIDs) and vitamins with 9.6%, 7%, and 6.8% frequencies were the highest frequently asked questions, respectively. Based on the results, patients do not receive enough information about their medications, from physicians and pharmacists. The DPICs have an important role to guide the people and provide the accurate drug and poison information and fill the absence of information that is not provided by medical staff. So, based on the important role of these centers, it is worth the Iran DPICs being introduced more to people, and we need more advertising around the country.
WHO. International Programme on Chemical Safety. (Accessed May 2016, 12, at http://www.who.int/ipcs/publications/training_poisons/gu idelines poison_control/en/index1.htm).
Bond C, Cynthia LR, Franke T. Clinical Pharmacy Services, Hospital Pharmacy Staffing, and Medication Errors in United States Hospitals. Pharmacotherapy 2002;22:134-47.
Geller RJ, Looser RW. Cost saving from poison center use by medical consumers. Vet Hum Toxicol 1985;27:521.
Shadnia S, Soltaninejad K, Sohrabi F, Rezvani M, Barari B, Abdollahi M. The performance of loghman-hakim drug and poison information center from 2006 to 2008. Iran J Pharm Res 2011;10:647-52.
Ghane T, Saberi S, Davoodabadi M. Descriptive Analysis of Recorded Phone Calls to Iran Drug and Poison Information Centers during 2011-2012. Asia Pac J Med Toxicol 2013;2:48-51.
Salamzadeh J. Clinical Pharmacy in Iran: Where Do We Stand? Iran J Pharm Res 2004;3:1-2.
Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MH, Eslami K, Karimzadeh I, et al. A two-year utilization of the pharmacist-operated drug information center in Iran. J Res Pharm Pract 2014;3:117-22.
Judith HH, Clyde RP. Gender roles, illness orientation and use of medical services. Social Sci Med 1983;17:129-37.
Rosenstock, I. The health belief model and preventive health behavior. Health Educ Behav 1974;2:354-86.
Lutz W, Cuaresma J, Abbasi-Shavazi M. Demography, Education, and Democracy: global trends and the case of Iran. Popul Dev Rev 2010;36:253-81.
Col NF, O’Connor RW. Estimating worldwide current antibiotic usage: report of Task Force 1. Rev Infect Dis
Cheraghali A, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East Mediterr Health J 2004;10:406-15.
FDO. Islamic Ripublic of Iran-Ministry of Health and Medical Education- Food and Drug Organization.(Accessed May 2016, 12, at http://fdo.behdasht.gov.ir/).
Kongpetch K. Drug Problem in Southeast and Southwest Asia. Ann NY Acad Sci 2004;446-57.